Open AccessIntravitreal bevacizumab as a primary treatment for idiopathic choroidal neovascularization
Author(s) -
Rizwan A. Cheema,
Javed Mushtaq,
Maheera A. Cheema
Publication year - 2011
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.84051
Subject(s) - medicine , bevacizumab , ophthalmology , choroidal neovascularization , visual acuity , fluorescein angiography , retinal , prospective cohort study , macular edema , surgery , chemotherapy
To report long-term outcomes of the use of intravitreal bevacizumab in subjects with idiopathic choroidal neovascularization (ICNV).